Dengue is an increasingly significant vector-borne infectious disease, with over 50 million cases reported in more than half the world's recognised independent states. Dengue fever, dengue haemorrhagic fever and dengue shock syndrome are distinct clinical forms of an infection that is caused by Dengue Virus, a member of the Flaviviridae family. All four well characterized serotypes of the virus can cause the full spectrum of disease from asymptomatic infection to life-threatening symptoms. For effective prevention and/or treatment of disease symptoms, early and rapid detection of virus in specimens collected from clinically suspected persons is a requirement that remains challenging. A positive laboratory diagnosis is essential to confirm dengue virus infection and hence to inform patient therapy. Here, we consider the pros and cons of currently available methods for identification, ranging from conventional to sophisticated tests. Reports indicate the use of a variety of diagnostic methods of varying sensitivity, highlighting the necessity for standardisation and quality control. Several novel approaches are in development and demand further evaluation.
Introduction
Dengue is a vector-borne viral disease of humans that is transmitted by mosquitoes of the genus Aedes. The World Health Organization (WHO) regards dengue as a major international public health concern in tropical and non-specific, which is problematic for correct clinical diagnosis. Unequivocal identification of dengue infection requires laboratory confirmation. The intent of this review is to outline the current laboratory methods for detection of dengue and to highlight areas where investigation may realise novel or improved diagnostic techniques.
Laboratory Methods
Precise laboratory diagnosis of dengue infection is important not only for appropriate, specialist clinical care but also for accurate public health surveillance. Currently, the most commonly used methods for dengue diagnosis include detection of: i) virus by cell culture; ii) viral nucleic acid; iii) DENV antigens or specific antibodies raised to them. Using a combination of two or more of these techniques increases the accuracy of diagnosis [2] [20] . Following onset of infection in patients, fever develops in synchrony with viraemia, when virus particles are found in plasma or serum, blood cells and tissues of the immune system (spleen, liver, lymph nodes, bone marrow). In this early stage, virus isolation, genome detection or antigen identification may each be used for diagnosis. However, after the acute phase has elapsed, serology is the method of choice to diagnose disease [2] .
Selecting from available laboratory diagnostic methods the most appropriate technique to use in each instance depends on the purpose for which testing is performed. These include diagnosis of primary and secondary infection, analysis of data for epidemiological surveys, pathological studies and vaccine development. Moreover, demand for rapidity, cost, and availability of appropriate laboratory resources should also be considerations in choice of methodology.
Virus Culture
Successful isolation of virus from viraemic patients requires that samples should be collected in the early stage of disease, usually within 5 days of onset of fever [24] . Common specimens include plasma, serum, peripheral blood, cerebrospinal fluid, pleural fluid and immune system tissues [2] . Three methods of DENV cultivation have been reported, involving inoculation of specimens into mosquitoes, various in vitro cultured cell lines, and intracerebrally in mice [2] [12] [24] . Inoculation of Toxorhynchites splendens and male Aedes albopictus mosquitoes is the most sensitive method [25] . Growth of virus is confirmed by detection of antigen in crushed heads of mosquitoes by serotype-specific immunofluorescence. The rearing and handling of potentially infectious mosquitoes require excellent facilities, adherence to health and safety protocols, and stringent conditions beyond the capacity of many laboratories. As an often more practical alternative, specimens may be inoculated into any of several widely available mosquito cell lines, such as AP61, Tra-284, C6/36, AP64 and CLA-1, or into mammalian cell lines like LLCMK2, Vero and BHK21 [26] . This is less sensitive than mosquito inoculation because no wild-type dengue virus induces cytopathic effects on in vitro cell lines. Therefore, cell cultures should be screened for specific evidence of infection by immunoassay. Inoculation of mice may be an option for virus isolation if other methods are not available. Specimens can be injected intracerebrally directly into suckling mice, which develop symptoms of encephalitis. Mouse brain is used for detection of viral antigen by immunofluorescence [2] . Despite the fact that virus isolation is the gold standard for identification of dengue infection, increasingly it is being replaced by newer molecular techniques. The main reasons for this are its lengthy procedure and requirement for viability of the virus in specimens. In addition, it is not possible to differentiate between primary and secondary infection. However, a new approach is under development which reduces time needed for detection by combining reverse transcription polymerase chain reaction (RT-PCR) with culture of whole peripheral blood [27] .
Viral Nucleic Acid Detection
Molecular techniques that are based on detection of viral nucleic acid are considered significant for the rapid identification of DENV serotypes and diagnosis of dengue infection. Common steps involved in genome detection are nucleic acid extraction, amplification and characterization of amplified products. Conventional RT-PCR, real time RT-PCR and nucleic acid sequence-based amplification (NASBA) are frequently used methods for genome detection. Major drawbacks of these techniques are potential false positive results due to sample contamination, inability to distinguish between primary and secondary infection, and relatively high cost [2] [28] .
A number of methodological adaptations of the basic RT-PCR technique have been developed in recent years. Of these variants, nested RT-PCR is the most widely used in laboratories worldwide [14] [29] . This involves a two-step process in which primers targeting core to pre-membrane gene regions are used for initial reverse transcription and amplification steps followed by a second PCR run with serotype-specific primers [21] . The product from the second PCR has little contamination from unwanted products of primer dimers, hairpins and alternative primer target sequences. Although RT-PCR is a rapid method for detection of DENV, it becomes less sensitive and more complicated with multiple steps of amplification. Subsequently, the two-step method was modified into an "all-in-one" multiplex RT-PCR by featuring a combination of the four (now five) serotypespecific oligonucleotide primers in a single reaction tube [15] . The amplicons are analyzed by agarose gel electrophoresis and then visualised by staining with ethidium bromide dye to differentiate between serotypes.
A recent advance has seen the development of real time RT-PCR for detection of DENV in acute phase serum samples [16] . This is a one-step assay used to quantify viral RNA genome using primer pairs and probes that are specific for each dengue serotype. Amplicons are detected in "real time" in a specialised PCR machine by using chemical formats like fluorophores, 5' nuclease, adjacent linear and hairpin oligonucleotide probes and self-fluorescing amplicons. It does not require electrophoresis. Its numerous advantages over RT-PCR include rapidity, the ability to provide quantitative measurements, a low contamination rate, a higher specificity, a higher sensitivity and easy standardisation. Collectively, these improvements mean real time RT-PCR is replacing conventional RT-PCR as the new gold standard for rapid diagnosis of dengue infection with acute phase serum samples [11] [17] [30] . TaqMan ® assay, one of the several types of real time RT-PCR, which uses a fluorogenic-labeled 5'-3' nuclease oligonucleotide probe, Taq DNA polymerase, is commonly used with high specificity and sensitivity. It is highly specific due to the sequence-specific hybridisation of the probe. Nevertheless, the primers and probes that have been reported previously may not be able to detect all DENV serotypes. Their sensitivity depends on homology with the targeted gene sequence of the particular virus being analysed [31] . Real time RT-PCR using the fluorescent double-stranded DNA-binding dye SYBR green ® is an alternative approach that has the advantage of simplicity in primer design and uses universal RT-PCR protocols but which is less specific. Shu et al. suggested that the one-step SYBR green I-based RT-PCR system has considerable potential for deployment in clinical diagnosis and epidemiological surveillance of viral disease due to its higher sensitivity than both serology and cell culture [18] . However, further investigation is required to confirm or refute this submission.
The NABSA assay is an isothermal RNA-specific amplification technique that does not require the use of a thermal cycler. An initial reverse transcription step is followed by transcription to synthesise RNA which is detected by fluorescence. It has significant specificity and sensitivity, comparable with that of virus isolation, and may be particularly useful in field studies of dengue infection [19] . The reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay is a recent modification that can be used for rapid detection of the DENV genome. This is based on the principle of a strand displacement reaction and a stem loop structure which amplifies the target to provide great specificity and selectivity. An attractive features of RT-LAMP is its ease of monitoring of amplification, which may be accomplished by SYBR green ® or ethidium bromide. Moreover, RT-LAMP requires less than one hour to yield results compared to the 3 -4 hours RT-PCR takes to run. However, performance relative to other nucleic acid amplification methods is currently not known [32] .
Serological Diagnosis
Various methods have been developed to analyse the antigen/antibody responses during dengue infection. In comparison to other techniques available, these are generally less expensive, easier to perform and, notably, can discriminate between primary and secondary infection. However, interpretation of a serological diagnosis can be difficult since a patient may be infected with more than one serotype, anti-dengue IgG antibody can cross-react with other Flavivirus antigens, past or recent infections are hard to distinguish, and levels of IgM may be undetectably low in certain secondary infections, which thus may miss cases. Standard serological tests for DENV detection include: haemagglutination inhibition (HI); neutralisation test; indirect immunofluorescence antibody test; enzyme-linked immunosorbent assay (ELISA); complement fixation, Western blotting; and rapid immunochromatography test. Of these, HI and ELISA are the most widely used methods for routine diagnosis of dengue infection [19] [26] [33] .
The HI test is a simple, cheap and rapid method of antibody detection which may be applied to large numbers of samples. Therefore, from an historical perspective it has been the most frequently used protocol for routine diagnosis of dengue. The HI test requires the analysis of paired sera collected from an individual over an interval of more than seven days, one during acute infection and another in the convalescent phase. Since the HI antibody persists for a long time, this is an ideal test for sero-epidemiological studies. Traditionally, it has been used to detect DENV and to differentiate primary and secondary dengue infections. As may be expected, primary infection is characterised by a slow evolution of HI antibody whereas secondary infection is notable for a rapid and elevated anamnestic response. For a positive test there may be a four-fold or greater increase in antibody titre between acute and convalescent sera. By convention, titres more than 2560 have come to represent secondary infection while those less than 1280 indicate primary infection. A major disadvantage presented by the HI test is the challenge to differentiate between closely related Flaviviridae members, such as dengue and Japanese encephalitis, a problem that is exacerbated by previous vaccination against Japanese encephalitis and yellow fever. Therefore, diagnosis of dengue infection by this test alone should not be considered reliable [19] [21] [34] . Moreover, HI cannot provide an early diagnosis. For this reason, the popularity of the HI test has reduced commensurate with the increased availability of more sensitive serological techniques such as ELISA.
ELISA based on immunoglobulin (Ig)M and IgG antibodies is a more efficient and popular serological test due to its simplicity, high specificity and great sensitivity. However, such antibodies can persist in the peripheral circulation for extended periods which may lead to errors in interpretation of diagnosis [2] [21]. Anti-DENV IgM is produced for a short duration during both primary and secondary infection. In primary infection, IgM rises rapidly and is usually identified after 2 -3 days. Titres reach a peak at about 14 days, then wane gradually to undetectable levels over 2 -3 months. Shortly after this time anti-DENV IgG appears. In secondary infection, IgM concentrations are maximal around 2 weeks after acute infection and then diminish to negligibility by 4 weeks. Unlike for primary infection, IgG appears quite rapidly, sometimes earlier than the IgM response [26] [35]. In both primary and secondary dengue infection, a rise in DENV E/M protein-specific IgM can be measured by IgM antibody capture (MAC). This has a slightly greater sensitivity than HI using paired sera for diagnosis of dengue in an individual. However, at present it is not possible to use MAC ELISA to identify dengue serotype as antibodies to DENV 1 -4 (and most probably DENV 5) are highly cross-reactive. Recently, a MAC ELISA that distinguishes serotype has been proposed but this requires further evaluation [36] . IgG E/M-specific antibody capture (GAC) ELISA enables measurement of IgG antibodies for up to 10 months after infection, thereby facilitating detection of recent and past dengue infection. An indirect IgG ELISA has also been developed that is comparable to the HI test and likewise can be used to differentiate primary from secondary dengue infection [37] . As for other serological tests, a four-fold or greater rise in dengue-specific IgG in acute and convalescent paired sera is indicative of recent infection [2] . It is recommended that analysis of paired serum samples from acute and convalescent phases should be performed by both MAC-ELISA and IgG ELISA in order to provide confirmation of results [21] . IgM/IgG ratio is often used to discriminate primary and secondary dengue infection. If the ratio of IgM to IgG, as measured by titre, is more than 1.2, the serum sample is considered as taken from primary infection, while an IgM/IgG ratio of less than 1.2 is indicative of secondary infection [2] [38]. The IgG avidity test, a newer approach, has proved to be beneficial for determining primary and secondary dengue infections. IgG avidity index, which requires only a single sample of acute phase serum, is used to characterise dengue infection. While it shows promise, however, this test is currently not readily accessible globally [39] . A number of commercial test kits that claim rapid detection of anti-dengue IgM and IgG have been marketed in the past few years [40] . Unfortunately, the accuracy of some of these ready-made kits has either been questioned, is unknown because proper validation studies have not been performed or the results not made publically available [41] - [43] .
DENV NS1 antigen has gained considerable interest as a new biomarker for early diagnosis of dengue infection [44] - [46] . NS1 antigen is abundant in serum of patients during the early stage of infection [47] . It can be detected in peripheral blood before the formation of antibodies, from the first day after onset of fever up to day 9. Studies revealed that the detection rate of NS1 antigen is higher in acute primary infection than in acute secondary infection [10] . All serotype-specific NS1 assays are highly specific for detection and determination of the appropriate serotype [44] . Hence, assay for NS1 antigen provides a potential means for the early diagnosis of dengue infection [46] .
Conclusions
Diagnostic methodologies for the identification of dengue that are based on the detection of DENV-specific antibodies are considered the mainstay of clinical diagnosis of this important infectious disease. These techniques are widely employed because they are convenient to use, provide rapid results, are reasonably accurate, and are cheap to perform. The traditional HI test has been largely replaced by ELISA based on detection of IgM and IgG because of its reported high degree of specificity and sensitivity. However, some contradictory findings suggest the need for supplementary assessment. Detection of NS1 antigen and antibodies specific to it is a novel serological strategy that is showing promise for rapid identification. Further development of this assay should focus on the feasibility of its use in small-scale laboratories and at reduced expense.
The last decade has seen a rapid and considerable improvement in molecular methods of diagnosis. Due to their high sensitivity, tests founded on molecular strategies are looking to replace virus isolation, which is a lengthy and labour-intensive process, as the gold standard method of dengue detection. Real time RT-PCR based on TaqMan ® or SYBR green ® , NABSA assay and RT-LAMP are recent advances in molecular techniques, each of which has a high degree of specificity and sensitivity comparable to that of virus isolation. However, a requirement for quality assurance demands further evaluation and comparison with the most sensitive methods that are currently available.
